Insider Transactions in Q1 2025 at Xeris Biopharma Holdings, Inc. (XERS)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 31
2025
|
Beth Hecht Officer |
BUY
Grant, award, or other acquisition
|
Direct |
185,000
+11.72%
|
-
|
|
Jan 31
2025
|
Beth Hecht Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
144,284
-5.46%
|
$432,852
$3.56 P/Share
|
|
Jan 31
2025
|
John Patrick Shannon Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
800,000
+22.94%
|
-
|
|
Jan 31
2025
|
John Patrick Shannon Jr Director |
SELL
Payment of exercise price or tax liability
|
Direct |
221,500
-5.4%
|
$664,500
$3.56 P/Share
|
|
Jan 31
2025
|
Kevin Mc Culloch Officer |
BUY
Grant, award, or other acquisition
|
Direct |
185,000
+9.9%
|
-
|
|
Jan 31
2025
|
Kevin Mc Culloch Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
78,134
-2.51%
|
$234,402
$3.56 P/Share
|
|
Jan 31
2025
|
Kenneth Erland Johnson Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
41,318
-5.87%
|
$123,954
$3.56 P/Share
|
|
Jan 31
2025
|
Steven Pieper Officer |
BUY
Grant, award, or other acquisition
|
Direct |
185,000
+11.54%
|
-
|
|
Jan 31
2025
|
Steven Pieper Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
177,200
-6.49%
|
$531,600
$3.56 P/Share
|
|
Jan 03
2025
|
Beth Hecht Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
32,039
-2.31%
|
$96,117
$3.61 P/Share
|
|
Jan 03
2025
|
Steven Pieper Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
32,059
-2.22%
|
$96,177
$3.61 P/Share
|
|
Jan 03
2025
|
Kenneth Erland Johnson Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,401
-3.31%
|
$37,203
$3.61 P/Share
|
|
Jan 03
2025
|
Kevin Mc Culloch Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
24,501
-1.53%
|
$73,503
$3.61 P/Share
|
|
Jan 03
2025
|
John Patrick Shannon Jr Director |
SELL
Payment of exercise price or tax liability
|
Direct |
39,443
-1.84%
|
$118,329
$3.61 P/Share
|